1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: December 7-13, 2025
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: December 7-13, 2025

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs

Event Date: 12/09/2025
Location: Washington, DC
Subject: Product Regulation
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several RAI Services Company representatives

Event Date: 12/09/2025
Location: Washington, DC
Subject: Field Outcome Data and Analytics
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several PreBorn representatives

Event Date: 12/10/2025
Location: Washington, DC
Subject: Association of Clinical Research Organizations (ACRO) Annual Meeting; Speaker: Challenges and Opportunities in the Current Development Environment Globally
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry

Event Date: 12/10/2025
Location: Silver Spring, MD
Subject: Potential Partnerships and Opportunities
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Shereef Elnahal (Oregon Health and Sciences University (OHSU));

Event Date: 12/11/2025
Location: Virtual 
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Senator Bill Cassidy, M.D. (R-LA)

Event Date: 12/11/2025
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Senator James Lankford (R-OK)

Event Date: 12/11/2025
Location: Virtual 
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Senator Maggie Hassan (D-NH)

Event Date: 12/11/2025
Location: Durham, NC
Subject: Novartis Groundbreaking Event
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, and other stakeholders

Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs

Event Date: 12/11/2025
Location: Washington, DC
Subject: American Telemedicine Association (ATA) EDGE Annual Telehealth Policy Conference; Speaker: Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, and other stakeholders

Official Name: Sean R. Keveney, Chief Counsel

No Significant Event

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Human Foods

Event Date: 12/08/2025
Location: College Park, MD
Subject: Laboratory Testing Issues of Mutual Interest
FDA Participant/Group: LARRY MORRIS; KIS HALE; DONALD PRATER; 
Non FDA Participant/Group: Association of Public Health Laboratories representatives

Event Date: 12/10/2025
Location: Washington, DC
Subject: Tufts University and Food Tank Ultra-Processed Foods and U.S. Health Policy Luncheon; Panelist: State and Federal Policy Updates
FDA Participant/Group: N/A
Non FDA Participant/Group: Food industry, academia, government, and other stakeholders

Event Date: 12/11/2025
Location: College Park, MD
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Safe Food Coalition representatives

Event Date: 12/12/2025
Location: College Park, MD
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: LARRY MORRIS; CONRAD CHOINIERE; MARK HARTMAN; DONALD PRATER; ROBIN MCKINNON; 
Non FDA Participant/Group: Western Growers Association representatives

Event Date: 12/12/2025
Location: College Park, MD
Subject: Dietary Supplement Issues of Mutual Interest
FDA Participant/Group: CARA WELCH; LARRY MORRIS; DONALD PRATER; 
Non FDA Participant/Group: Dietary Supplement Trade Associations representatives

Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations

No Significant Event

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives

Event Date: 12/09/2025
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: BRIAN FAHEY; KARIM MIKHAIL; 
Non FDA Participant/Group: Vivex representatives

Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations

No Significant Event

Official Name: Vinayak Prasad, M.D., M.P.H., Director, Center for Biologics and Research

No Significant Event

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

Event Date: 12/08/2025
Location: Washington, DC
Subject: 22nd Global Cardio Vascular Clinical Trialists (CVCT) Forum; Speaker: Evolving Regulatory Framework for Evidence Standards in AI-Driven Cardiovascular Tools
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, academia, and other stakeholders

Official Name: Richard Pazdur, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products

No Significant Event

Official Name: Timothy Schell, Ph.D., Director, Center for Veterinary Medicine

No Significant Event

Back to Top